Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 189
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Numinus Applies for International Patent Filing of Psychedelics Production Process
Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...
Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...
Mindmed Announces Voting Results for Annual General and Special Meeting
GH Research Reports First Quarter 2022 Financial Results and Provides Business...
COMPASS Pathways presents largest ever study of psilocybin therapy, at American...
Incannex announces positive results from phase 2 clinical trial investigating the...
PT330 – Dick Simon – Researching Ethnobotanical Efficacy and the Search...
Exploring Ketamine’s Antimicrobial Effects & Fungal Sources: Part 2
PT329 – Dr. Scott Shannon – The Board of Psychedelic Medicine...
Load more